Cargando…
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
INTRODUCTION: Patients with thoracic malignancies are at increased risk for mortality from coronavirus disease 2019 (COVID-19), and a large number of intertwined prognostic variables have been identified so far. METHODS: Capitalizing data from the Thoracic Cancers International COVID-19 Collaboratio...
Ejemplares similares
-
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
por: Bestvina, Christine M., et al.
Publicado: (2022) -
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
por: Whisenant, Jennifer G., et al.
Publicado: (2020) -
P09.18 COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)
por: Whisenant, J., et al.
Publicado: (2021) -
MA12.03 A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper)
por: Wong, S., et al.
Publicado: (2021) -
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience
por: Trama, Annalisa, et al.
Publicado: (2020)